Literature DB >> 9147498

A study of the interrelationship between and comparative interrater reliability of the SAPS, SANS and PANSS.

R M Norman1, A K Malla, L Cortese, F Diaz.   

Abstract

We assessed the comparative interrater reliability of the SANS/SAPS and PANSS as measures of symptomatology in schizophrenia and also examined the interrelationship between scores on these instruments. Two experienced raters used these Scales to assess positive and negative symptoms in a group of 85 patients with a DSM III-R diagnosis of schizophrenia. Ratings were based on structured clinical interviews, review of case notes and consultation with staff familiar with the patients. Comparable levels of interrater reliability were found for each system of measuring symptomatology, but levels of interrater reliability were on the whole lower than have been reported in the past. There were high correlations between overall indices of positive and negative symptomatology derived from the two measurement systems.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9147498     DOI: 10.1016/0920-9964(95)00055-0

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  20 in total

1.  The European Schizophrenia Cohort (EuroSC): a naturalistic prognostic and economic study.

Authors:  Paul E Bebbington; Matthias Angermeyer; Jean-Michel Azorin; Traolach Brugha; Reinhold Kilian; Sonia Johnson; Mondher Toumi; Asa Kornfeld
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-09       Impact factor: 4.328

2.  Clinical characteristics and objective living conditions in relation to quality of life among community-based individuals of schizophrenia in Hong Kong.

Authors:  Frederick Ka Ching Yeung; Sunny Ho Wan Chan
Journal:  Qual Life Res       Date:  2006-09-07       Impact factor: 4.147

3.  An initial study of modifiable and non-modifiable factors for late-life psychosis.

Authors:  Obiora E Onwuameze; Susan K Schultz; Sergio Paradiso
Journal:  Int J Psychiatry Med       Date:  2011       Impact factor: 1.210

4.  Converting positive and negative symptom scores between PANSS and SAPS/SANS.

Authors:  Theo G M van Erp; Adrian Preda; Dana Nguyen; Lawrence Faziola; Jessica Turner; Juan Bustillo; Aysenil Belger; Kelvin O Lim; Sarah McEwen; James Voyvodic; Daniel H Mathalon; Judith Ford; Steven G Potkin
Journal:  Schizophr Res       Date:  2013-12-11       Impact factor: 4.939

5.  Symptom assessment in early psychosis: the use of well-established rating scales in clinical high-risk and recent-onset populations.

Authors:  Daniel Fulford; Rahel Pearson; Barbara K Stuart; Melissa Fisher; Daniel H Mathalon; Sophia Vinogradov; Rachel L Loewy
Journal:  Psychiatry Res       Date:  2014-08-01       Impact factor: 3.222

6.  Does sex influence the relation between symptoms and neurocognitive functions in schizophrenia?

Authors:  A K Malla; R M Norman; S Morrison-Stewart; P C Williamson; E Helmes; L Cortese
Journal:  J Psychiatry Neurosci       Date:  2001-01       Impact factor: 6.186

7.  Residential area and social contacts in schizophrenia. Results from the European Schizophrenia Cohort (EuroSC).

Authors:  Georg Schomerus; Dirk Heider; Matthias C Angermeyer; Paul E Bebbington; Jean-Michel Azorin; Traolach Brugha; Mondher Toumi
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-06-27       Impact factor: 4.328

8.  Looking for childhood-onset schizophrenia: diagnostic algorithms for classifying children and adolescents with psychosis.

Authors:  Deanna Greenstein; Rachna Kataria; Peter Gochman; Abhijit Dasgupta; James D Malley; Judith Rapoport; Nitin Gogtay
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-07-14       Impact factor: 2.576

9.  Path models of quality of life among people with schizophrenia living in the community in Hong Kong.

Authors:  Sunny Ho Wan Chan; Frederick Ka Ching Yeung
Journal:  Community Ment Health J       Date:  2007-11-30

10.  A positive take on schizophrenia negative symptom scales: Converting scores between the SANS, NSA and SDS.

Authors:  Adrian Preda; Dana D Nguyen; Juan R Bustillo; Aysenil Belger; Daniel S O'Leary; Sarah McEwen; Shichun Ling; Lawrence Faziola; Daniel H Mathalon; Judith M Ford; Steven G Potkin; Theo G M van Erp
Journal:  Schizophr Res       Date:  2018-06-20       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.